VEEV:NYE-Veeva Systems Inc. Class A (USD)

EQUITY | Health Information Services | New York Stock Exchange

Last Closing

USD 193.63

Change

+1.96 (+1.02)%

Market Cap

USD 6.08B

Volume

0.91M

Analyst Target

USD 304.05
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Veeva Systems Inc is a provider of industry-specific, cloud-based software solutions for the life sciences industry.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-30 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
SOLV Solventum Corp.

N/A

USD 10.78B
DOCS Doximity Inc

N/A

USD 6.81B
WEAV Weave Communications Inc

N/A

USD 0.81B
MPLN MultiPlan Corporation

N/A

USD 0.16B
AMWL American Well Corp

N/A

USD 0.12B
OWLT Owlet Inc

N/A

USD 0.05B
PHR Phreesia Inc

N/A

N/A
FOXO FOXO Technologies Inc.

N/A

N/A
EVH Evolent Health Inc

N/A

N/A
TDOC Teladoc Inc

N/A

N/A

ETFs Containing VEEV

ZPW:CA BMO US Put Write ETF 7.28 % 0.71 %

N/A

CAD 0.06B
CURG:LSE VanEck Genomics and Healt.. 6.89 % 0.00 %

N/A

USD 6.97M
EKG First Trust Nasdaq Lux Di.. 6.82 % 0.00 %

N/A

USD 2.52M
CURE:XETRA VanEck Genomics and Healt.. 5.89 % 0.00 %

N/A

N/A
FDOC:LSE Fidelity Digital Health U.. 5.51 % 0.00 %

N/A

USD 2.95M
FDHT:XETRA Fidelity Digital Health U.. 4.82 % 0.00 %

N/A

N/A
FDHT 4.69 % 0.00 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QRH:CA 0.00 % 1.20 %

N/A

N/A
EASI 0.00 % 0.75 %

N/A

N/A
ZPW-U:CA BMO US Put Write ETF 0.00 % 0.00 %

N/A

N/A
WELL:LSE Hanetf Icav - Han-Gins He.. 0.00 % 0.00 %

N/A

N/A
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
CLDL Direxion Daily Cloud Comp.. 0.00 % 0.00 %

N/A

USD 3.96M
LCG Sterling Capital Focus Eq.. 0.00 % 0.00 %

N/A

USD 0.05B
WCLD:LSE WisdomTree Cloud Computin.. 0.00 % 0.00 %

N/A

USD 0.32B
KLWD:LSE WisdomTree Cloud Computin.. 0.00 % 0.00 %

N/A

USD 0.32B

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.58% 80% B- 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.58% 80% B- 25% F
Trailing 12 Months  
Capital Gain -4.50% 100% F 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.50% 100% F 20% F
Trailing 5 Years  
Capital Gain 17.18% 75% C 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.18% 75% C 46% F
Average Annual (5 Year Horizon)  
Capital Gain 12.01% 73% C 75% C
Dividend Return 12.01% 73% C 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 41.65% 73% C 22% F
Risk Adjusted Return 28.85% 73% C 50% F
Market Capitalization 6.08B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Information Services) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 109.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike